Dougherty & Co Starts MAKO Surgical (MAKO) at Buy; Valuation Rich...But For A Reason
Tweet Send to a FriendGet Alerts MAKO Hot Sheet
Price: $11.51 --0%
Rating Summary:
4 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 8
Rating Summary:
4 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 12 | New: 8
Trade MAKO Now!
Dougherty & Co initiates coverage on MAKO Surgical (NASDAQ: MAKO) with a Buy. PT $35.00.
Analyst, Junaid Husain, said, "Our recommendation is predicated on the following: 1) Robotics & MAKOplasty: A Minimally-Invasive Approach to Orthopedic Surgery. We’re fans of the RIO System and RESTORIS implants which are used in MAKOplasty, a minimally-invasive orthopedic surgical procedure; 2) MAKOplasty PKA: Better Clinical & Economic Outcomes - Attractive Market; 3) MAKOplasty THA: Still Early in the Rollout, But Could Be Meaningful...We See MAKOplasty As a Valuable Marketing Tool for Hospitals & Surgeons; and 4) Solid MAKOplasty Growth Should Drive Robust Sales and Breakeven by CY13."
For an analyst ratings summary and ratings history on MAKO Surgical click here. For more ratings news on MAKO Surgical click here.
Shares of MAKO Surgical closed at $25.46 yesterday, with a 52 week range of $20.90-$45.15.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Junaid Husain, said, "Our recommendation is predicated on the following: 1) Robotics & MAKOplasty: A Minimally-Invasive Approach to Orthopedic Surgery. We’re fans of the RIO System and RESTORIS implants which are used in MAKOplasty, a minimally-invasive orthopedic surgical procedure; 2) MAKOplasty PKA: Better Clinical & Economic Outcomes - Attractive Market; 3) MAKOplasty THA: Still Early in the Rollout, But Could Be Meaningful...We See MAKOplasty As a Valuable Marketing Tool for Hospitals & Surgeons; and 4) Solid MAKOplasty Growth Should Drive Robust Sales and Breakeven by CY13."
For an analyst ratings summary and ratings history on MAKO Surgical click here. For more ratings news on MAKO Surgical click here.
Shares of MAKO Surgical closed at $25.46 yesterday, with a 52 week range of $20.90-$45.15.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BTIG Starts ING U.S (VOYA) at Buy, Shares 'Significantly Undervalued'
- Stifel Nicolaus Resumes Alliant Techsystems (ATK) at Hold
- ISI Group Starts Qwest Communications (Q) at Neutral
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
